NEUROMETRIX : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)

NURO

10

--------------------------------------------------------------------------------

Comparison of Quarters Ended September 30, 2021 and 2020

Cost of Revenues and Gross Profit

--------------------------------------------------------------------------------

$ 376.0 21.4 %

Research and Development

General and Administrative

Other income primarily includes interest income.

12

--------------------------------------------------------------------------------

Comparison of Nine Months Ended September 30, 2021 and 2020

Cost of Revenues and Gross Profit

--------------------------------------------------------------------------------

Sales and marketing expense in the nine months ended September 30, 2021 decreased by 3.4% from the same period in the prior year due to a $76,000 reduction in personnel spending and a $39,000 reduction in facility and depreciation costs offset by an increase in advertising spending of $83,000.

General and Administrative

Other income primarily includes interest income.

Liquidity and Capital Resources

14

--------------------------------------------------------------------------------

-

15

--------------------------------------------------------------------------------

Cautionary Note Regarding Forward-Looking Statements

© Edgar Online, source Glimpses